Enterprise Therapeutics reports positive phase 2 cystic fibrosis trial

🌐 Investing.com (CY) — 2026-05-12

Enterprise Therapeutics has announced positive results from its phase 2 trial for a cystic fibrosis treatment. The promising data highlights their commitment to developing therapies for this serious health condition.

Markets Health Enterprise Therapeutics cystic fibrosis clinical trial healthcare

Read original source →

How significant is this year's budget?
The Sydney Morning Herald — 2026-05-12
The federal budget at a glance
The Sydney Morning Herald — 2026-05-12
Trump’s war a $15 billion budget hit – and it could get much worse
The Sydney Morning Herald — 2026-05-12
Young Australians faced a dark future. Now the treasurer has cued the sun
The Sydney Morning Herald — 2026-05-12
NSW short-changed by Chalmers on key infrastructure funding
The Sydney Morning Herald — 2026-05-12
How the tax changes impact property investors and first home buyers
The Sydney Morning Herald — 2026-05-12

Enterprise Therapeutics reports positive phase 2 cystic fibrosis trial

AI Summary

Related Articles

How significant is this year's budget?

The federal budget at a glance

Trump’s war a $15 billion budget hit – and it could get much worse

Young Australians faced a dark future. Now the treasurer has cued the sun

NSW short-changed by Chalmers on key infrastructure funding

How the tax changes impact property investors and first home buyers